Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Vaginal sling procedures are becoming more popular for treating urinary incontinence, especially in women facing severe bladder control issues. Those experiencing urine leakage during activities like coughing or sneezing find relief through these surgeries. The growing number of women dealing with urinary incontinence, particularly stress urinary incontinence, is a key factor driving market growth. The increasing population of elderly women contributes to this trend. Additionally, advancements in the materials used for creating advanced vaginal slings and improvements in technology for these procedures provide lucrative opportunities for market expansion.
Urinary incontinence is a significant health concern with broad social and financial impacts. While it's less common in younger women, its prevalence rises, especially around menopause and later in life. Factors like age, family history, and lower urinary tract symptoms contribute to this condition, which is more prevalent in women than in men. Chronic diseases like diabetes and neurological conditions can also lead to urinary incontinence. Stress urinary incontinence, affecting around 15 million adult women in the US in 2017, is the most widespread form among women, often linked to pregnancy, childbirth, and menopause. This rise in cases globally has led to increased adoption of vaginal sling procedures to address urinary incontinence. With the growing prevalence of this condition, the market for treatments like vaginal sling surgeries is expanding.
Moreover, the cause of incontinence, whether due to bladder or sphincter dysfunction or a combination, has not been extensively studied. In women, both moderate and severe incontinence have a prevalence ranging from 3% to 17%. Severe incontinence is less common in young women but significantly increases between the ages of 70 and 80. Stress incontinence, accounting for less than 10% of cases, is often linked to factors like prostate surgery, trauma, or neurological injury. As the prevalence of urinary incontinence continues to grow, the market is expected to see further expansion.
The escalating demand for vaginal sling procedures in response to the increasing prevalence of urinary incontinence, especially among women experiencing stress urinary incontinence, propels market growth. This rise is further amplified by the expanding population of elderly women seeking relief from severe bladder control issues through these surgical interventions. Advances in materials and technology related to vaginal slings contribute to the market's expansion, offering patients more effective and innovative treatment options. Urinary incontinence, a significant health concern with widespread societal and economic implications, has seen a surge, particularly around menopause and later in life. Stress urinary incontinence, the most common form among women, is associated with factors like pregnancy, childbirth, and menopause, driving the adoption of vaginal sling surgeries globally. With the growing prevalence of urinary incontinence and the effectiveness of vaginal sling procedures, the market is poised for continued growth in the foreseeable future.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | Increasing disposable income |
| Market Dynamics | Increased healthcare spending and increasing awarenessRising number of elderly women |
Vaginal Slings Market Highlights:
Global Vaginal Slings Market Overview
Vaginal Slings Market Size was valued at USD 1.45 Billion in 2023. The vaginal slings market industry is projected to grow from USD 1.62 Billion in 2024 to USD 3.69 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.77% during the forecast period (2024 - 2032). The prevalence of stress urine incontinence is on the rise, and the number of elderly women in the female population is rising as well. These are the main market drivers driving the market share for vaginal slings. Additionally, market participants' intense interest in the creation of technologically improved vaginal slings has increased demand for the sector and propelled the expansion of the vaginal slings market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
November 2021: Hologic has disclosed its intention to introduce the NovaSure V5 global endometrial ablation (GEA) device for treating abnormal uterine bleeding at the forthcoming American Association of Gynecologic Laparoscopists (AAGL) 50th Global Congress, which will be held both virtually and in-person from November 14-17 in Austin, Texas. This information was conveyed in a press release issued by the company. The NovaSure system received first approval from the U.S. Food and Drug Administration in 2001 and has been utilized in the treatment of more than 3 million patients as of 2018. The equipment is specifically engineered to enhance the comfort and dexterity of physicians, while also being capable of accommodating various widths of the cervical canal. The NovaSure V5 device is a cutting-edge invention that builds upon a 20-year track record of unparalleled performance and incorporates improvements based on valuable consumer input. Hologic's GYN Surgical Solutions division maintains its dedication to prioritizing physicians and the women they care for by actively seeking and incorporating their feedback into the development of new innovations. Their constant endeavor is to collaborate with physicians in order to attain superior results for ladies.
Vaginal Slings Market Trends
- Rising number of elderly women is driving the market growth
The market for vaginal slings is anticipated to increase in the future due to the rising number of elderly women. The senior population (65 years and over) is referred to as the female geriatric population. Vaginal slings are used to treat and control stress urine incontinence (SUI), which affects a section of the expanding female geriatric population. For instance, women made up 55% of the population aged 65 or over in October 2020, according to World Population Ageing 2020 Highlights, issued by the United Nations, a US-based intergovernmental organization. They currently account for 62% of those who are 80 or older. According to predictions, the proportion of elderly persons in the population would increase from 9.3% in 2020 to 16.0% in 2050. Therefore, the market CAGR for vaginal slings is expected to develop in the future due to the rising number of elderly women.
The creation of technologically sophisticated vaginal slings is a crucial trend that is becoming more and more popular in the vaginal sling market. To maintain their position in the vaginal sling industry, major firms are creating vaginal slings that are technologically advanced. For instance, US-based Caldera Medical, a maker of medical equipment, debuted Desara One in May 2020. It is a blue one incision sling system with completely integrated mesh for female stress urine incontinence that helps to reduce mesh roping, twisting, and ripping while maximizing connection strength. This innovative device is streamlined with an anchor-mesh transition that is made to lay flat under the urethra and is intended to lessen tissue injury and dissection. Thus, driving the vaginal slings market revenue.
Vaginal Slings Market Segment Insights
Vaginal Slings Method Insights
The vaginal slings market segmentation, based on method includes Retropubic Method, Transobturator Method and Others. The transobturator method segment dominated the market due to their lower risk of causing significant blood vessel, bladder, or intestine damage, ease of use, and effectiveness comparable to tension-free vaginal tape slings. For instance, single-incision mini-slings are a secure and reliable treatment for female urodynamic stress incontinence, according to a Pubmed article from November 2021. According to this study, the Solyx single-incision slings outperformed the MiniArc due to their better objective cure rate and lower chance of surgical failure. Transobturator sling benefits will therefore spur market expansion in the future.
Vaginal Slings Type Insights
The vaginal slings market segmentation, based on type, includes Tension-Free Vaginal Tape Slings and Others. The tension-free vaginal tape slings category generated the most income due to manufacturers' increasing interest in creating items like vaginal mesh and vaginal micro slings to address urine incontinence. Additionally, tension-free vaginal tape slings are widely used since they are secure, less invasive, and quick to complete.
Figure 1: Vaginal Slings Market, by Type, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Vaginal Slings End User Insights
The vaginal slings market segmentation, based on end user, includes Hospitals, Ambulatory Surgical Centers and others. The hospitals category generated the most income as a result of the significant deployment of minimally invasive robotic surgery in hospital settings. With the goal of assisting rural hospitals and promoting the rehabilitation and building of rural healthcare institutions, the Biden Administration issued $500 million in American Rescue Act grants in 2021. These kinds of developments are also anticipated to drive the general market dynamics in the ensuing years, together with the gradually rising surgery rate in hospitals.
Vaginal Slings Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American vaginal slings market area will dominate this market because women in this area are more likely to suffer from stress urine incontinence due to the early adoption of innovative vaginal slings and increased prevalence. A growing prevalence of mixed incontinence in women and urgency incontinence in men was found to be related with heart failure among chronic diseases. Because of this, the market will rise in the future despite a growing prevalence of diseases.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: VAGINAL SLINGS MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe vaginal slings market accounts for the second-largest market share due to the UK's high rate of urinary tract infections among women. Nearly 3-6 million individuals in the UK suffer from urine incontinence, according to figures from the National Health Service. The demand for vaginal mesh sling treatments is expected to increase faster than expected due to the frequency of this condition and the development of cutting-edge tools for minimally invasive surgery. Further, the German vaginal slings market held the largest market share, and the UK vaginal slings market was the fastest growing market in the European region
The Asia-Pacific Vaginal slings Market is expected to grow at the fastest CAGR from 2023 to 2032 because of the large population base, rising disposable incomes, and increased patient knowledge of advanced urinary incontinence care. In addition, established insurance programs and the availability of cutting-edge healthcare infrastructure are a couple of the other elements driving the market in this area. Moreover, China’s vaginal slings market held the largest market share, and the Indian vaginal slings market was the fastest growing market in the Asia-Pacific region.
Vaginal Slings Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the vaginal slings market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, vaginal slings industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the vaginal slings industry to benefit clients and increase the market sector. In recent years, the vaginal slings industry has offered some of the most significant advantages to market. Major players in the vaginal slings market attempting to increase market demand by investing in research and development operations include A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy) and Promedon (Argentina).
Ethicon US LLC (Ethicon), a division of Johnson & Johnson, is a provider of medical equipment through its subsidiaries Ethicon Inc. and Ethicon Endo-Surgery Inc. It creates and sells surgical tools and devices. The company's main offerings include staplers, clip appliers, energy devices, trocars, hemostats, endocutters, endoscopic instruments, suturing devices, irrigation products, meshes, and allografts. Its products are used to treat colorectal, thoracic, and hernia disorders, cancer, and obesity during minimally invasive and open surgical procedures.
Coloplast A/S (Coloplast) creates, markets, and provides services related to ostomy, respiratory, continence, urology, skin, and wound care. Urisheaths, ostomy bags, urine bags, catheters, anal irrigation systems, sling goods, advanced foam dressings and hydrocolloid dressings for protection against pressure injuries and skin damage, as well as cleansers, skin protectants, moisturizers, anti-fungal, and hand cleansers, are some of its main products. SenSura, SpeediCath, Persiteen, Conveen, InterDry, Biatain, Brava, and Comfeel are just a few of the brands that the business sells its goods under.
Key Companies in the vaginal slings market include
-
A.M.I. GmbH (Austria)
-
Betatech Medical (Turkey)
-
Boston Scientific Corporation (USA)
-
CL Medical (France)
-
Coloplast Corp (Denmark)
-
Ethicon Inc. (USA)
-
Herniamesh S.r.l. (Italy)
-
Promedon (Argentina)
Vaginal Slings Industry Developments
February 2022: Agency for Medical Innovation (AMI) was purchased by Evoco, a biotechnology business with US headquarters, for an unknown sum. Evoco collaborates closely with the present management team and is looking to maximize value creation potential with this acquisition. Manufacturer of vaginal slings Agency for Medical Innovation is situated in Austria.
November 2021: Desara TVez has been introduced by Caldera Medical, a manufacturer of medical devices that creates best-in-class surgical tools for the treatment of polyps, pelvic organ prolapse, and stress urine incontinence.
September 2021: A strategic sales and distribution agreement between UroCure and LiNA Medical USA, two companies that specialize in minimally invasive medical devices for gynecology and urology, is announced. The UroCure ArcTV sling and its developing women's health portfolio are joined with LiNA's US national sales force and offering of device solutions in this combined distribution and product development relationship, which takes advantage of the capabilities of both businesses.
Vaginal slings Market Segmentation
Vaginal Slings Method Outlook (USD Billion, 2018-2032)
-
Retropubic Method
-
Transobturator Method
-
Others
Vaginal Slings Type Outlook (USD Billion, 2018-2032)
-
Tension-Free Vaginal Tape Slings
-
Others
Vaginal Slings End User Outlook (USD Billion, 2018-2032)
-
Hospitals
-
Ambulatory Surgical Centers
-
Others
Vaginal Slings Regional Outlook (USD Billion, 2018-2032)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
